CLINICAL ENDOCRINOLOGY, ISSN 0300-0664, 05/2019, Volume 90, Issue 5, pp. 670 - 679
Objective To describe clinical practice experience of C-11-Metomidate PET/CT as an adjunct to adrenal vein sampling (AVS) in the lateralization of...
DIAGNOSIS | RENIN | SUBTYPES | CONSENSUS | PREVALENCE | SUPPRESSION | adrenal | primary aldosteronism | ENDOCRINOLOGY & METABOLISM | C-11-Metomidate PET | adrenal vein sampling | OUTCOMES | hypertension
DIAGNOSIS | RENIN | SUBTYPES | CONSENSUS | PREVALENCE | SUPPRESSION | adrenal | primary aldosteronism | ENDOCRINOLOGY & METABOLISM | C-11-Metomidate PET | adrenal vein sampling | OUTCOMES | hypertension
Journal Article
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, ISSN 0021-972X, 01/2012, Volume 97, Issue 1, pp. 100 - 109
Context: Identification of unilateral aldosterone-producing (Conn's) adenomas has traditionally required lateralization by the invasive and technically...
HUMAN ADRENOCORTICAL-CELLS | PRIMARY HYPERALDOSTERONISM | DIAGNOSIS | DEXAMETHASONE-SUPPRESSION | RESPONSE PATHWAY | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | CLINICAL DECISION-MAKING | ENDOCRINOLOGY & METABOLISM | BIOCHEMICAL SUCCESS | ADRENAL INCIDENTALOMAS | HYPERTENSIVE PATIENTS
HUMAN ADRENOCORTICAL-CELLS | PRIMARY HYPERALDOSTERONISM | DIAGNOSIS | DEXAMETHASONE-SUPPRESSION | RESPONSE PATHWAY | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | CLINICAL DECISION-MAKING | ENDOCRINOLOGY & METABOLISM | BIOCHEMICAL SUCCESS | ADRENAL INCIDENTALOMAS | HYPERTENSIVE PATIENTS
Journal Article
WORLD JOURNAL OF SURGERY, ISSN 0364-2313, 01/2013, Volume 37, Issue 1, pp. 107 - 112
Adrenocortical carcinoma (ACC) is a rare cancer for which little level evidence exists to guide management. F-18-FDG PET (F-18-fluorodeoxyglucose positron...
FDG-PET | SURGERY | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | FLUORODEOXYGLUCOSE | LYMPHOMA | ADRENAL-TUMORS | STANDARDIZED UPTAKE VALUE | F-18-FLUORODEOXYGLUCOSE | CARCINOMA | COMPUTED-TOMOGRAPHY
FDG-PET | SURGERY | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | FLUORODEOXYGLUCOSE | LYMPHOMA | ADRENAL-TUMORS | STANDARDIZED UPTAKE VALUE | F-18-FLUORODEOXYGLUCOSE | CARCINOMA | COMPUTED-TOMOGRAPHY
Journal Article
Hormone and Metabolic Research, ISSN 0018-5043, 12/2017, Volume 49, Issue 12, pp. 929 - 935
Abstract Differentiation of unilateral from bilateral aldosterone hypersecretion is the essential step in the clinical practice of primary aldosteronism (PA)....
Review | adrenal tumor | adrenal adenoma | adrenal cortex | aldosterone | I-131-19-IODOCHOLESTEROL | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | SCINTIGRAPHY | TUMORS | AGENT | POSITRON-EMISSION-TOMOGRAPHY | DEXAMETHASONE-SUPPRESSION | ADRENAL MASSES | ENDOCRINOLOGY & METABOLISM | ADENOMAS
Review | adrenal tumor | adrenal adenoma | adrenal cortex | aldosterone | I-131-19-IODOCHOLESTEROL | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | SCINTIGRAPHY | TUMORS | AGENT | POSITRON-EMISSION-TOMOGRAPHY | DEXAMETHASONE-SUPPRESSION | ADRENAL MASSES | ENDOCRINOLOGY & METABOLISM | ADENOMAS
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 04/2018, Volume 31, Issue 5, pp. 522 - 531
Abstract Primary aldosteronism (PA) is now considered as one of leading causes of secondary hypertension, accounting for 5–10% of all hypertensive patients and...
Hypertension | Treatment | Primary aldosteronism | Genetics | Blood pressure | Diagnosis | Aldosterone | blood pressure | treatment | aldosterone | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | diagnosis | UNILATERAL PRIMARY ALDOSTERONISM | MINERALOCORTICOID RECEPTOR ANTAGONIST | GLOMERULAR-FILTRATION-RATE | genetics | POSITRON-EMISSION-TOMOGRAPHY | IMAGE-GUIDED ABLATION | primary aldosteronism | PLASMA-RENIN ACTIVITY | BLOOD-PRESSURE CONTROL | PERIPHERAL VASCULAR DISEASE | LEFT-VENTRICULAR MASS | CHRONIC KIDNEY-DISEASE | hypertension | Reviews
Hypertension | Treatment | Primary aldosteronism | Genetics | Blood pressure | Diagnosis | Aldosterone | blood pressure | treatment | aldosterone | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | diagnosis | UNILATERAL PRIMARY ALDOSTERONISM | MINERALOCORTICOID RECEPTOR ANTAGONIST | GLOMERULAR-FILTRATION-RATE | genetics | POSITRON-EMISSION-TOMOGRAPHY | IMAGE-GUIDED ABLATION | primary aldosteronism | PLASMA-RENIN ACTIVITY | BLOOD-PRESSURE CONTROL | PERIPHERAL VASCULAR DISEASE | LEFT-VENTRICULAR MASS | CHRONIC KIDNEY-DISEASE | hypertension | Reviews
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2012, Volume 97, Issue 3, pp. 914 - 922
Context: In advanced adrenocortical carcinoma (ACC), many patients have progressive disease despite standard treatment, indicating a need for new treatment...
CAPECITABINE | POSITRON-EMISSION-TOMOGRAPHY | MITOTANE | C-11-METOMIDATE | ENDOCRINOLOGY & METABOLISM | PHASE-II | RADIOTHERAPY | PROGNOSTIC VALUE | TUMORS | CANCER | EXPRESSION | Humans | Middle Aged | Male | Treatment Outcome | Etomidate - therapeutic use | Etomidate - analogs & derivatives | Disease-Free Survival | Iodine Radioisotopes - therapeutic use | Adrenocortical Carcinoma - radiotherapy | Aged, 80 and over | Adrenal Cortex Neoplasms - radiotherapy | Adult | Female | Aged
CAPECITABINE | POSITRON-EMISSION-TOMOGRAPHY | MITOTANE | C-11-METOMIDATE | ENDOCRINOLOGY & METABOLISM | PHASE-II | RADIOTHERAPY | PROGNOSTIC VALUE | TUMORS | CANCER | EXPRESSION | Humans | Middle Aged | Male | Treatment Outcome | Etomidate - therapeutic use | Etomidate - analogs & derivatives | Disease-Free Survival | Iodine Radioisotopes - therapeutic use | Adrenocortical Carcinoma - radiotherapy | Aged, 80 and over | Adrenal Cortex Neoplasms - radiotherapy | Adult | Female | Aged
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 10/2012, Volume 106, Issue 5, pp. 586 - 594
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Due to its rarity, heterogeneity, and a lack of a comprehensive understanding of the...
outcomes | management | adrenocortical carcinoma | SURGERY | ADJUVANT MITOTANE | LONG-TERM SURVIVAL | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | CHEMICAL-SHIFT | NATURAL-HISTORY | PHASE-II TRIAL | LAPAROSCOPIC ADRENALECTOMY | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | CONTRAST-ENHANCED CT | ADRENAL-CORTICAL CARCINOMA | Adrenal Cortex Neoplasms - therapy | Adrenal Cortex Neoplasms - diagnosis | Humans | Carcinoma | Cancer
outcomes | management | adrenocortical carcinoma | SURGERY | ADJUVANT MITOTANE | LONG-TERM SURVIVAL | 11-BETA-HYDROXYLASE TRACER C-11-METOMIDATE | CHEMICAL-SHIFT | NATURAL-HISTORY | PHASE-II TRIAL | LAPAROSCOPIC ADRENALECTOMY | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | CONTRAST-ENHANCED CT | ADRENAL-CORTICAL CARCINOMA | Adrenal Cortex Neoplasms - therapy | Adrenal Cortex Neoplasms - diagnosis | Humans | Carcinoma | Cancer
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 03/2006, Volume 91, Issue 3, pp. 920 - 925
Objective: Patients with adrenocortical cancer are submitted to multiple imaging procedures for diagnosis of recurrence and staging. The aim of this...
FDG-PET | SURVIVAL | LUNG-CANCER | C-11-METOMIDATE | INTRAVENOUS CONTRAST | ENDOCRINOLOGY & METABOLISM | EXPERIENCE | STANDARDIZED UPTAKE VALUE | ADRENAL-CORTICAL CARCINOMA | F-18-FLUORODEOXYGLUCOSE | FEATURES | Prognosis | Humans | Middle Aged | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Adrenal Cortex Neoplasms - pathology | Neoplasm Metastasis | Image Processing, Computer-Assisted | Survival Analysis | Adult | Female | Fluorodeoxyglucose F18 | Aged | Radiopharmaceuticals | Adrenal Cortex Neoplasms - mortality
FDG-PET | SURVIVAL | LUNG-CANCER | C-11-METOMIDATE | INTRAVENOUS CONTRAST | ENDOCRINOLOGY & METABOLISM | EXPERIENCE | STANDARDIZED UPTAKE VALUE | ADRENAL-CORTICAL CARCINOMA | F-18-FLUORODEOXYGLUCOSE | FEATURES | Prognosis | Humans | Middle Aged | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Adrenal Cortex Neoplasms - pathology | Neoplasm Metastasis | Image Processing, Computer-Assisted | Survival Analysis | Adult | Female | Fluorodeoxyglucose F18 | Aged | Radiopharmaceuticals | Adrenal Cortex Neoplasms - mortality
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 04/2013, Volume 98, Issue 4, pp. 1508 - 1518
Context: Adrenal tumors are highly prevalent and represent a wide range of different pathological entities. Conventional imaging often provides only limited...
IN-VITRO | MASSES | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | INCIDENTALOMAS | ENDOCRINOLOGY & METABOLISM | F-18-FDG | ADRENOCORTICAL CARCINOMA | DELAYED ENHANCED CT | LIPID-POOR | PET | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Carcinoma - diagnostic imaging | Etomidate - adverse effects | Iodine Radioisotopes - adverse effects | Young Adult | Adrenal Gland Neoplasms - epidemiology | Carcinoma - epidemiology | Sensitivity and Specificity | Multimodal Imaging - methods | Aged, 80 and over | Adult | Female | Whole Body Imaging | Multimodal Imaging - adverse effects | Adrenal Gland Neoplasms - diagnostic imaging | Carcinoma - physiopathology | Etomidate - analogs & derivatives | Adrenal Gland Neoplasms - physiopathology | Adolescent | Aged | Clinical Trials, Phase I as Topic | Clinical Trials, Phase II as Topic
IN-VITRO | MASSES | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | INCIDENTALOMAS | ENDOCRINOLOGY & METABOLISM | F-18-FDG | ADRENOCORTICAL CARCINOMA | DELAYED ENHANCED CT | LIPID-POOR | PET | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Carcinoma - diagnostic imaging | Etomidate - adverse effects | Iodine Radioisotopes - adverse effects | Young Adult | Adrenal Gland Neoplasms - epidemiology | Carcinoma - epidemiology | Sensitivity and Specificity | Multimodal Imaging - methods | Aged, 80 and over | Adult | Female | Whole Body Imaging | Multimodal Imaging - adverse effects | Adrenal Gland Neoplasms - diagnostic imaging | Carcinoma - physiopathology | Etomidate - analogs & derivatives | Adrenal Gland Neoplasms - physiopathology | Adolescent | Aged | Clinical Trials, Phase I as Topic | Clinical Trials, Phase II as Topic
Journal Article
Nuclear Medicine and Biology, ISSN 0969-8051, 01/2019, Volume 68-69, pp. 14 - 21
Primary aldosteronism accounts for 6–15% of hypertension cases, the single biggest contributor to global morbidity and mortality. Whilst ~50% of these patients...
Metomidate | Adrenal glands | Fluorine-18 radiochemistry | Primary aldosteronism | CYP11B2 | Positron emission tomography | ETOMIDATE | DIAGNOSIS | TRACERS | PREVALENCE | TUMORS | C-11-METOMIDATE | CORTEX | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Hypertension | Corticosteroids | PET imaging | Mortality | Cytochrome P-450 | Fluorides | Health aspects | Biomedical engineering | Radiochemical analysis | Fluorine | Glands | Radioactive tracers | Selectivity | Aldosterone | Blood | Fluoride | Metabolites | Precursors | Rodents | Surgery | Tomography | Adrenal gland | Half-life | Lesions | Half life | Urine | Enzymes | Excretion | Medical imaging | Radiolabelling | Organs | Positron emission | Aldosterone synthase | Fluorine isotopes | Radioactive half-life | Steroid 11β-hydroxylase | Morbidity | Cyclotrons | Emissions | Autoradiography | Anion exchanging | In vivo methods and tests
Metomidate | Adrenal glands | Fluorine-18 radiochemistry | Primary aldosteronism | CYP11B2 | Positron emission tomography | ETOMIDATE | DIAGNOSIS | TRACERS | PREVALENCE | TUMORS | C-11-METOMIDATE | CORTEX | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Hypertension | Corticosteroids | PET imaging | Mortality | Cytochrome P-450 | Fluorides | Health aspects | Biomedical engineering | Radiochemical analysis | Fluorine | Glands | Radioactive tracers | Selectivity | Aldosterone | Blood | Fluoride | Metabolites | Precursors | Rodents | Surgery | Tomography | Adrenal gland | Half-life | Lesions | Half life | Urine | Enzymes | Excretion | Medical imaging | Radiolabelling | Organs | Positron emission | Aldosterone synthase | Fluorine isotopes | Radioactive half-life | Steroid 11β-hydroxylase | Morbidity | Cyclotrons | Emissions | Autoradiography | Anion exchanging | In vivo methods and tests
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 04/2019, Volume 62, Issue 4, pp. 190 - 197
[11C]metomidate ([11C]MTO) is a radiotracer widely used to detect disorders of adrenocortical origin by positron emission tomography (PET) imaging. [11C]MTO...
SPE purification | [11C]MTO | captive‐solvent 11C‐methylation | Synthra MeIPlus | adrenocortical PET imaging | CHEMISTRY, ANALYTICAL | CHEMISTRY, MEDICINAL | [C-11]MTO | BIOCHEMICAL RESEARCH METHODS | TUMORS | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | METOMIDATE | captive-solvent C-11-methylation | PET | Methylation | Biomedical engineering
SPE purification | [11C]MTO | captive‐solvent 11C‐methylation | Synthra MeIPlus | adrenocortical PET imaging | CHEMISTRY, ANALYTICAL | CHEMISTRY, MEDICINAL | [C-11]MTO | BIOCHEMICAL RESEARCH METHODS | TUMORS | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | METOMIDATE | captive-solvent C-11-methylation | PET | Methylation | Biomedical engineering
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 03/2003, Volume 30, Issue 3, pp. 403 - 410
The diagnostic potential of positron emission tomography (PET) with carbon-11 metomidate in patients with adrenocortical cancer (ACC) was evaluated. Thirteen...
adrenocortical cancer | treatment effect | ADRENAL MASSES | C-11-metomidate | TUMORS | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
adrenocortical cancer | treatment effect | ADRENAL MASSES | C-11-metomidate | TUMORS | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 04/2006, Volume 91, Issue 4, pp. 1410 - 1414
Context: Adrenal incidentalomas are common findings necessitating extensive laboratory work-up and repetitive radiological examinations. Positron emission...
DIAGNOSIS | C-11-METOMIDATE | MANAGEMENT | ENDOCRINOLOGY & METABOLISM | INAPPARENT ADRENAL MASS | INCIDENTALOMA | EXPERIENCE | PET | Data Interpretation, Statistical | Humans | Middle Aged | Antineoplastic Agents | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Positron-Emission Tomography | Adrenal Cortex Neoplasms - pathology | Etomidate - analogs & derivatives | Ethics | Image Processing, Computer-Assisted | Female | Aged | Radiopharmaceuticals | Data Interpretation; Statistical | Medical and Health Sciences | Medicin och hälsovetenskap | Radiopharmaceuticals/diagnostic use | Image Processing; Computer-Assisted | MEDICINE | Etomidate/analogs & derivatives/diagnostic use | MEDICIN | Adrenal Cortex Neoplasms/pathology/radionuclide imaging | Antineoplastic Agents/diagnostic use
DIAGNOSIS | C-11-METOMIDATE | MANAGEMENT | ENDOCRINOLOGY & METABOLISM | INAPPARENT ADRENAL MASS | INCIDENTALOMA | EXPERIENCE | PET | Data Interpretation, Statistical | Humans | Middle Aged | Antineoplastic Agents | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Positron-Emission Tomography | Adrenal Cortex Neoplasms - pathology | Etomidate - analogs & derivatives | Ethics | Image Processing, Computer-Assisted | Female | Aged | Radiopharmaceuticals | Data Interpretation; Statistical | Medical and Health Sciences | Medicin och hälsovetenskap | Radiopharmaceuticals/diagnostic use | Image Processing; Computer-Assisted | MEDICINE | Etomidate/analogs & derivatives/diagnostic use | MEDICIN | Adrenal Cortex Neoplasms/pathology/radionuclide imaging | Antineoplastic Agents/diagnostic use
Journal Article
Current Opinion in Endocrinology, Diabetes and Obesity, ISSN 1752-296X, 06/2015, Volume 22, Issue 3, pp. 150 - 156
Purpose of reviewPrimary aldosteronism is increasingly recognized as a common secondary cause of hypertension. Successful demonstration of a unilateral cause...
PET-CT | metomidate | primary aldosteronism/hyperaldosteronism | MANAGEMENT | SCINTIGRAPHY | UNILATERAL PRIMARY ALDOSTERONISM | TUMORS | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | primary aldosteronism | ENDOCRINOLOGY & METABOLISM | hyperaldosteronism | HYPERTENSION | CLINICAL-PREDICTION SCORE | ADRENALECTOMY | Hyperaldosteronism - diagnostic imaging | Positron-Emission Tomography - methods | Humans | Etomidate - analogs & derivatives | ADRENAL CORTEX AND MEDULLA | Edited by Anand Vaidya
PET-CT | metomidate | primary aldosteronism/hyperaldosteronism | MANAGEMENT | SCINTIGRAPHY | UNILATERAL PRIMARY ALDOSTERONISM | TUMORS | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | primary aldosteronism | ENDOCRINOLOGY & METABOLISM | hyperaldosteronism | HYPERTENSION | CLINICAL-PREDICTION SCORE | ADRENALECTOMY | Hyperaldosteronism - diagnostic imaging | Positron-Emission Tomography - methods | Humans | Etomidate - analogs & derivatives | ADRENAL CORTEX AND MEDULLA | Edited by Anand Vaidya
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2013, Volume 98, Issue 7, pp. 2755 - 2764
Context: Imaging with [123I]iodometomidate ([123I]IMTO) has been shown to diagnose adrenocortical lesions with high sensitivity and specificity. Objective: Our...
IODOMETHYL-NORCHOLESTEROL I-131 | DIAGNOSIS | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | ADRENAL ADENOMAS | ENDOCRINOLOGY & METABOLISM | F-18-FDG | F-18-FLUORODEOXYGLUCOSE | TUMORS | PRIMARY ALDOSTERONISM | COMPUTED-TOMOGRAPHY | Adrenal Cortex Neoplasms - blood | Adrenal Cortex Neoplasms - secretion | Prospective Studies | Humans | Middle Aged | Hydrocortisone - secretion | Tomography, Emission-Computed, Single-Photon | Male | Tomography, X-Ray Computed | Neoplasm Recurrence, Local - secretion | Adrenal Cortex - pathology | Neoplasm Recurrence, Local - pathology | Adrenocortical Carcinoma - pathology | Etomidate - pharmacokinetics | Adrenal Cortex - secretion | Neoplasm Recurrence, Local - diagnostic imaging | Sensitivity and Specificity | Adult | Female | Whole Body Imaging | Hydrocortisone - blood | Adrenocortical Carcinoma - secretion | Radiopharmaceuticals - pharmacokinetics | Adrenocortical Carcinoma - secondary | Aldosterone - blood | Aldosterone - secretion | Adrenal Cortex Neoplasms - diagnostic imaging | Adrenal Cortex Neoplasms - pathology | Iodine Radioisotopes - pharmacokinetics | Etomidate - analogs & derivatives | Pilot Projects | Adrenocortical Carcinoma - diagnostic imaging | Adrenal Cortex - diagnostic imaging | Aged | Neoplasm Staging | Cohort Studies
IODOMETHYL-NORCHOLESTEROL I-131 | DIAGNOSIS | POSITRON-EMISSION-TOMOGRAPHY | C-11-METOMIDATE | ADRENAL ADENOMAS | ENDOCRINOLOGY & METABOLISM | F-18-FDG | F-18-FLUORODEOXYGLUCOSE | TUMORS | PRIMARY ALDOSTERONISM | COMPUTED-TOMOGRAPHY | Adrenal Cortex Neoplasms - blood | Adrenal Cortex Neoplasms - secretion | Prospective Studies | Humans | Middle Aged | Hydrocortisone - secretion | Tomography, Emission-Computed, Single-Photon | Male | Tomography, X-Ray Computed | Neoplasm Recurrence, Local - secretion | Adrenal Cortex - pathology | Neoplasm Recurrence, Local - pathology | Adrenocortical Carcinoma - pathology | Etomidate - pharmacokinetics | Adrenal Cortex - secretion | Neoplasm Recurrence, Local - diagnostic imaging | Sensitivity and Specificity | Adult | Female | Whole Body Imaging | Hydrocortisone - blood | Adrenocortical Carcinoma - secretion | Radiopharmaceuticals - pharmacokinetics | Adrenocortical Carcinoma - secondary | Aldosterone - blood | Aldosterone - secretion | Adrenal Cortex Neoplasms - diagnostic imaging | Adrenal Cortex Neoplasms - pathology | Iodine Radioisotopes - pharmacokinetics | Etomidate - analogs & derivatives | Pilot Projects | Adrenocortical Carcinoma - diagnostic imaging | Adrenal Cortex - diagnostic imaging | Aged | Neoplasm Staging | Cohort Studies
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2006, Volume 91, Issue 7, pp. 2665 - 2671
Context: Adrenocortical carcinomas are uncommon, and their evaluation by [18F]fluorodeoxyglucose positron emission tomography (FDG PET) has not been well...
FDG-PET | MASSES | C-11-METOMIDATE | BENIGN | ENDOCRINOLOGY & METABOLISM | ADRENAL-CORTICAL CARCINOMA | F-18-FLUORODEOXYGLUCOSE | CANCER | NONADENOMAS | ADENOMAS | Humans | Middle Aged | Child, Preschool | False Negative Reactions | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Neoplasm Metastasis - diagnostic imaging | Positron-Emission Tomography | Liver Neoplasms - diagnostic imaging | Lung Neoplasms - secondary | Neoplasm Recurrence, Local - diagnostic imaging | Adult | Female | Fluorodeoxyglucose F18 | Lung Neoplasms - diagnostic imaging | Aged | Liver Neoplasms - secondary | Child
FDG-PET | MASSES | C-11-METOMIDATE | BENIGN | ENDOCRINOLOGY & METABOLISM | ADRENAL-CORTICAL CARCINOMA | F-18-FLUORODEOXYGLUCOSE | CANCER | NONADENOMAS | ADENOMAS | Humans | Middle Aged | Child, Preschool | False Negative Reactions | Adrenal Cortex Neoplasms - diagnostic imaging | Male | Neoplasm Metastasis - diagnostic imaging | Positron-Emission Tomography | Liver Neoplasms - diagnostic imaging | Lung Neoplasms - secondary | Neoplasm Recurrence, Local - diagnostic imaging | Adult | Female | Fluorodeoxyglucose F18 | Lung Neoplasms - diagnostic imaging | Aged | Liver Neoplasms - secondary | Child
Journal Article
Endocrine Practice, ISSN 1530-891X, 04/2014, Volume 20, Issue 4, pp. 375 - 377
Journal Article